Ledger.Open graph →
SEC Form D · filed July 27, 2017

Cyrus Biotechnology, Inc

Offering
$8.0M
Sold
$8.0M
Exemption
Rule 506(b)
Industry
Other Technology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Mark O'Sullivan · New York, NYExec · DirectorChristian M. Zugel · Red Bank, NJExecJamie Lurie · New York, NYExec · DirectorGus Tai · Redwood City, CADirectorEric Bell · Falls Church, VADirectorChad Waite · Somerville, MADirectorKevan D. Kurt · Santa Rosa, CAExec · DirectorWilliam H. Hinkle · Geyserville, CAExec · DirectorSeth W. Alvord · Westport, CTExecGus Tai · Seattle, WADirectorEric Bell · Seattle, WADirectorChad Waite · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗